Hormone replacement therapy and cancer : the current status of research and practice /

Bibliographic Details
Corporate Author: IMS Workshop
Other Authors: Genazzani, Andrea R.
Format: Conference Proceeding Book
Language:English
Published: Boca Raton : Parthenon Pub. Group, [2002]
Series:Controversial issues in climacteric medicine series.
Subjects:
Table of Contents:
  • Oncogenes and tumor suppressor genes
  • Telomerase and cancer
  • Matrix metalloproteinases
  • Biological basis of angiogenesis and role of vascular endothelial growth factor-D
  • Breast cancer : epidemiology, pathology and natural history
  • Genes and heredity in breast cancer
  • Endocrine, paracrine and intracrine mechanisms of growth regulation in normal and malignant breast epithelium
  • Chemoprevention of breast cancer with tamoxifen : recent experience and future perspectives
  • Hormonal therapy of breast cancer
  • Hormone replacement therapy and mammographic breast density
  • Hormone replacement therapy, insulin-like frowth factor 1 and breast cancer
  • Postmenopausal hormone use and breast cancer risk : reassessment of the evidence
  • The use of hormonal therapy for management of severe postmenopausal symptoms following breast cancer
  • Endometrial cancer : epidemiology, pathology and natural history
  • Endocrine, paracrine and intracrine mechanisms of growth regulation in normal and malignant endometrial epithelium
  • Chemoprevention and endocrine therapy of endometrial carcinoma
  • Hormone replacement therapy and endometrial cancer
  • Endometrial stromal tumors - are they hormonally sensitive?
  • Epidemiology of colorectal cancer
  • Colon cancer : pathology and natural history
  • Estrogen receptors, estrogens and colon cancer
  • Cyclo-oxygenase-2 : an endogenous tumor promotor and target for the chemoprevention of colorectal cancer and other neoplastic diseases
  • Hormone replacement therapy and colon cancer
  • Cutaneous malignant melanoma : epidemiology, endocrine features and hormone replacement therapy
  • BRCA1-BRCA2 and ovarian cancer
  • Estrogen replacement therapy use and risk of ovarian cancer : results from two Italian studies and review of the literature
  • Understanding HRT risks and benefits and the new science of HRT
  • Pulsed estrogen therapy may lead to lower breast stimulation than with daily continuousestrogen exposure
  • Transdermal estrogen therapy and the risk of breast cancer : a clinical appraisal
  • The effects of selective estrogen receptor modulators on the endometrium
  • Safety and tolerability profile of Livial
  • Preclinical and clinical development of new progesterone receptor antagonists with high receptor specifity for breast cancer treatment
  • More than bones : hormone replacement therapy for mind and body